Expertise in
38
conditions

Dr. Shannon L. Schmidt

Oncology | Hematology
ThedaCare Medical CenterShawano
100 County Road B, 
Shawano, WI 
Accepting New Patients
17 Years of Experience
Expertise in
38
conditions
ThedaCare Medical CenterShawano
100 County Road B, 
Shawano, WI 

Overview

I can’t think of a job any more meaningful than one that allows you to be there to support people who have been diagnosed with cancer and help as they navigate such a difficult time in life. To me, a strong patientprovider relationship is so essential. It’s also incredibly important for patients to be active participants in their care and I encourage this by keeping them educated and updated with as much information as possible. The best way to approach the treatment process is by feeling confident about the plan.

Dr. Schmidt is highly rated in 38 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, B-Cell Lymphoma, Angiosarcoma, and Bone Marrow Aspiration.

Dr. Schmidt is board certified in Medical Oncology, American Board Of Internal Medicine (2016), American Board Of Internal Medicine (2016), and Internal Medicine, American Board Of Internal Medicine (2012). She is actively involved in clinical research, participating in 5 clinical trials. Dr. Schmidt is currently accepting new patients.

Graduate Institution

Medical College Of Wisconsin, 2009

Specialties

Oncology
Hematology

Licenses

Internal Medicine in WI

Board Certifications

Medical Oncology, American Board Of Internal Medicine (2016)
American Board Of Internal Medicine (2016)
Internal Medicine, American Board Of Internal Medicine (2012)

Fellowships

Medical College of Wisconsin 2016

Hospital Affiliations

Thedacare Regional Medical Center - Appleton Inc
Thedacare Regional Med Ctr - Neenah
Thedacare Medical Center-Waupaca
Thedacare Medical Center - New London
Thedacare Medical Center - Shawano

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Common Ground Healthcare
  • OTHER COMMERCIAL
Common Ground Healthcare Cooperative
  • EPO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Network Health
  • HMO
Quartz
  • HMO
  • POS
  • PPO
Quartz Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Security Health
  • EPO
  • HMO
  • INDEMNITY
  • POS
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 21 Less Insurance Carriers -

Locations

ThedaCare Medical CenterShawano
100 County Road B, Shawano, WI 54166

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 02, 2026
Intervention Type: Other
Study Phase: Phase 3
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: August 31, 2026
Intervention Type: Other, Radiation, Procedure, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3
(CompassHER2-pCR): Preoperative THP and Postoperative HP in Patients Who Achieve a Pathologic Complete Response
(CompassHER2-pCR): Preoperative THP and Postoperative HP in Patients Who Achieve a Pathologic Complete Response
Enrollment Status: Active_not_recruiting
Publish Date: July 10, 2026
Intervention Type: Procedure, Biological, Drug, Radiation
Study Drugs: Docetaxel, Nab-Paclitaxel, Paclitaxel, Pertuzumab, Trastuzumab, Trastuzumab Emtansine
Study Phase: Phase 2
A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently With Radiotherapy Versus Radiotherapy Alone for Inflammatory Breast Cancer
A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently With Radiotherapy Versus Radiotherapy Alone for Inflammatory Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2026
Intervention Type: Drug, Procedure, Radiation, Other
Study Drug: Olaparib
Study Phase: Phase 2
The CompassHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): CompassHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared With T-DM1 and Tucatinib
The CompassHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): CompassHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared With T-DM1 and Tucatinib
Enrollment Status: Active_not_recruiting
Publish Date: June 15, 2026
Intervention Type: Other, Biological, Drug
Study Drugs: Trastuzumab Emtansine, Tucatinib
Study Phase: Phase 3
View 4 Less Clinical Trials
Similar Doctors
Expertise in
50
conditions
Dr. Michael P. Mullane
Hematology | Oncology
Expertise in
50
conditions
Dr. Michael P. Mullane
Hematology | Oncology
Referral may be required
Before you request

Aurora BayCare Medical Center

2845 Greenbrier Rd, 
Green Bay, WI 
 (38.3 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Mullane is a Hematologist and an Oncologist practicing medicine in Green Bay, Wisconsin. Dr. Mullane is highly rated in 50 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, and Monoclonal Gammopathy of Undetermined Significance (MGUS). Dr. Mullane is board certified in American Board Of Internal Medicine, Hematology. Dr. Mullane is currently accepting new patients.

Expertise in
28
conditions
Dr. Ryan H. Engel
Oncology | Hematology
Expertise in
28
conditions
Dr. Ryan H. Engel
Oncology | Hematology
Referral may be required
Before you request

ThedaCare Regional Medical Center Appleton Inc

2500 E Capitol Dr., 
Appleton, WI 
 (34.4 miles away)
Languages Spoken:
English, Italian, Spanish
See accepted insurances
Accepting New Patients

Ryan Engel is an Oncologist and a Hematologist practicing medicine in Appleton, Wisconsin. Dr. Engel is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Engel is board certified in American Board Of Internal Medicine, Hematology, American Board Of Internal Medicine (2007), Internal Medicine, American Board Of Internal Medicine (2003), and Medical Oncology, American Board Of Internal Medicine (2007). Dr. Engel is currently accepting new patients.

Expertise in
28
conditions
Dr. Zahid N. Dar
Hematology | Oncology
Expertise in
28
conditions
Dr. Zahid N. Dar
Hematology | Oncology
Referral may be required
Before you request

Vince Lombardi Cancer Clinic

855 N Westhaven Dr, 
Oshkosh, WI 
 (50.7 miles away)
920-456-7870
Languages Spoken:
English, Hindi, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Zahid Dar is a Hematologist and an Oncologist practicing medicine in Oshkosh, Wisconsin. Dr. Dar is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Metastatic Pleural Tumor, Paget Disease of the Breast, Familial Pancreatic Cancer, and Pleuropulmonary Blastoma. Dr. Dar is board certified in American Board Of Internal Medicine, Medical Oncology. Dr. Dar is currently accepting new patients.

Frequently Asked Questions about Dr. Shannon L. Schmidt

How do I make an appointment with Dr. Shannon L. Schmidt?

You can book an appointment with Dr. Shannon L. Schmidt by calling their office at 715-526-2111. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Shannon L. Schmidt a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Shannon L. Schmidt is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Shannon L. Schmidt specialize in?

While Dr. Shannon L. Schmidt is a Oncology, they have specific expertise in Breast Cancer, Paget Disease of the Breast, and B-Cell Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Shannon L. Schmidt accept my insurance?

Dr. Shannon L. Schmidt accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 715-526-2111 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Schmidt's expertise for a condition
ConditionClose
    View All 10 Distinguished Conditions
    View All 28 Advanced Conditions
    View All 114 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile